ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Jasper Therapeutics Inc

Jasper Therapeutics Inc (JSPRW)

0.2209
0.0009
(0.41%)
Closed July 22 4:00PM
0.2209
0.00
( 0.00% )
Pre Market: 8:00PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.2209
Bid
0.1311
Ask
0.25
Volume
-
0.00 Day's Range 0.00
0.0351 52 Week Range 0.3818
Market Cap
Previous Close
0.2209
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
8,373
Shares Outstanding
15,085,553
Dividend Yield
-
PE Ratio
-4.95
Earnings Per Share (EPS)
-4.27
Revenue
-
Net Profit
-64.47M

About Jasper Therapeutics Inc

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem ce... Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Wilmington, Delaware, USA
Founded
1970
Jasper Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker JSPRW. The last closing price for Jasper Therapeutics was $0.22. Over the last year, Jasper Therapeutics shares have traded in a share price range of $ 0.0351 to $ 0.3818.

Jasper Therapeutics currently has 15,085,553 shares outstanding. The market capitalization of Jasper Therapeutics is $3.33 million. Jasper Therapeutics has a price to earnings ratio (PE ratio) of -4.95.

JSPRW Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.027113.98348813210.19380.230.17249974720.21264521CS
40.055933.87878787880.1650.230.16534830.20360874CS
120.081958.92086330940.1390.230.10183730.1819168CS
260.102386.25632377740.11860.27140.07197110.17505791CS
520.100984.08333333330.120.38180.0351199170.12982808CS
156-1.5091-87.23121387281.732.240.016280130.52005098CS
260-1.5091-87.23121387281.732.240.016280130.52005098CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NMHINatures Miracle Holding Inc
$ 0.9691
(176.89%)
5.79M
GPGreenPower Motor Company Inc
$ 1.79
(59.11%)
4
FEIMFrequency Electronics Inc
$ 13.34
(32.08%)
77.65k
LGHLWLion Group Holding Ltd
$ 0.0093
(30.99%)
156
ENGENGlobal Corp
$ 2.22
(29.82%)
258
RNAZTransCode Therapeutics Inc
$ 0.3173
(-59.96%)
284.54k
MIRAMIRA Pharmaceuticals Inc
$ 3.58
(-28.54%)
745.72k
CMAXCareMax Inc
$ 3.95
(-23.89%)
249.49k
NUKKNukkleus Inc
$ 0.3943
(-20.82%)
127.08k
XCURExicure Inc
$ 0.4128
(-17.41%)
5.59k
NMHINatures Miracle Holding Inc
$ 0.9691
(176.89%)
5.79M
LIFWMSP Recovery Inc
$ 0.6221
(22.77%)
2.96M
BREABrera Holdings PLC
$ 0.682
(-7.48%)
1.55M
SLNASelina Hospitality PLC
$ 0.0353
(-4.59%)
1.04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 14.52
(1.61%)
1M

Discussion

View Full Feed
RichieBoy RichieBoy 9 minutes ago
Well I'll tell you this much, after JAGX debacle

What a daunting disappointment for humanity that was, a formidable vexation to the spirit. I could really get behind a medical AI research program. Just as one example the big buzz right now is finding a way to block the protein dubbed
JAGX
#1 PATRIOTS_RSOX FAN #1 PATRIOTS_RSOX FAN 11 minutes ago
Note: due to the specific nature of SFLMaven stock, the prediction can be significantly excessive / unrealistic!
SFLM
Gooddolphin Gooddolphin 15 minutes ago
Not worried.. Accumulating as time moves on. :)
NSAV
TAKURI TAKURI 16 minutes ago
Someone purchased approximately 180 million (or more) stocks between 20:46:00 and 20:46:51...........
NWPN
ShadowDiviner72 ShadowDiviner72 17 minutes ago
That's peanuts. That's a market cap of 87 million dollars, for a drug, unique on his market, in cancer therapy, with the potential of generating billions in revenue...

That's really low
JAGX
maq1214 maq1214 20 minutes ago
I see 10 dollars incoming
JAGX
oilin07 oilin07 21 minutes ago
No
BLLB
TrendTrade2016 TrendTrade2016 23 minutes ago
NEXT .0030..THEN 0027
SMCE
archilles archilles 24 minutes ago
Can’t wait for RDGL to get IDE approval soon within days. Rocket is roaring and is ready to take off very soon !
RRRROOOO….OOMM!
RDGL
RealDutch RealDutch 25 minutes ago
Don't think so. It will remain at 60% of spot price. They want it to be as they want to make a new currency of it.
ITUP
Edward Edward 26 minutes ago
-
VXIT
RealDutch RealDutch 28 minutes ago
It does raise some questions. But...

The current purchase price is based on a cycle rate of 15 days. So every 15 days you will generate some profit and this will double over a 5-year period.
This is SWIM. (Systematic Wealth and Income Multiplier). Which we also have for Rice a
SIRI
floridaboy floridaboy 30 minutes ago
Ugly session yesterday, impatience continues to grow...
SAPX
LVerstee LVerstee 32 minutes ago
The buy back price?
ITUP
Handlamera Handlamera 35 minutes ago
I guess that the market will set the price and define the spread? That’s why the marketplace is set up?
ITUP
Edward Edward 36 minutes ago
LOL!!! How can anyone interpret my message as “being so upset”
Somehow your ability to read and comprehend has not improved in your time here.

So funny, so upset over a stock that is selling for .0016. LMAO.
VXIT
twiztedtriple6 twiztedtriple6 38 minutes ago
Probably so. It's the same thing that he did while he was CEO of BRNE.
BRNE
Investor2014 Investor2014 39 minutes ago
The SEC definition is at odds with clinical trial outcome statistics.

“Trial success is not material because that is the presumed outcome. Most companies would PR a trial success since that is a positive piece of news.”

If the SEC was right about their definition it wou
AVXL
Number sleven Number sleven 47 minutes ago
Nuke, Yes.
Sleven,
AMRN
glenn1919 glenn1919 48 minutes ago
TC......PSNY....GOEV......MULN.......https://stockcharts.com/h-sc/ui?s=TC&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=PSNY&p=W&b=5&g=0&id=p84354014936
https://stockcharts.com/h-sc/ui?s=GOEV&p=W&b=5&g=0&id=p843540149361
https://stockcharts.com/h-sc/ui?s=MULN&p=W
GOEV MULN PSNY
B_B! B_B! 50 minutes ago
Small-Cap Rotation or Death Sentence for Hedge Funds? It’s Too Early to Tell.
Investors should pay close attention to the behavior between small-cap and large-cap stocks
12h ago • By Michael A. Gayed

The stock market is dangerous right now and all investors are playing
NVDA

Your Recent History

Delayed Upgrade Clock